united states liquid biopsy potential testing market
TRANSCRIPT
© Renub Research Page 1 of 14
United States – Liquid Biopsy Potential
Testing Market & Volume Analysis to 2020
Renub Researchwww.renub.com
Published: January, 2016Copyright © 2016 Renub Research – All Rights Reserved
Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Liver Cancer
Other Cancers
© Renub Research Page 2 of 14
United States – Liquid Biopsy Testing Market - Overview
Liquid Biopsy Tests are emerging as a viable alternative to traditional methods for cancer
screening. A liquid biopsy is a new type of blood test that has the potential to transform
cancer treatment. Using this methodology, physicians avoid the traditional surgical and needle
biopsies they use to determine the existence of cancer in patients. In United States Liquid
Biopsy market; Screening Test is likely to capture major chunk of the market compared to
Monitoring Market. It is anticipated that Liquid Biopsy Testing will be more helpful for
monitoring cancer treatment and status after diagnosis than in screening for a cancer that may
be years or even decades in the making and not otherwise detectable.
United States – Liquid Biopsy Potential Screening Market Analysis: In the United States liquid
biopsy screening market, prostate cancer is the most popular segment. Lung cancer liquid
biopsy screening stands at the last spot.
United States – Liquid Biopsy Potential Treatment Monitoring Market Analysis: In the United
States liquid biopsy treatment monitoring market, breast cancer is the leading segment. Liver
cancer stands at the fifth spot.
Renub Research report titled “United States – Liquid Biopsy Potential Testing Market &
Volume Analysis to 2020” provides a comprehensive assessment of the fast–evolving, high–
growth of Liquid Biopsy Market. This 79 page report with 41 Figures analyses the United
States Liquid Biopsy Test Market and Volume by 5 Top Cancer Segment, Recent developments,
Major Deals along with the driving factors and challenges for Liquid Biopsy Market.
The United States Liquid Biopsy Potential Market has been analyzed from two view points
1. United States Liquid Biopsy Potential Screening Market & Test Volume (2015 – 2020)
The Top 5 Cancer Segments covered are:
1. Lung Cancer
2. Breast Cancer
© Renub Research Page 3 of 14
3. Colorectal Cancer
4. Prostate Cancer
5. Liver Cancer
2. United States Liquid Biopsy Potential Treatment Monitoring Market & Test Volume (2015
– 2020)
The Top 6 Cancer Segments covered are:
1. Lung Cancer
2. Breast Cancer
3. Colorectal Cancer
4. Prostate Cancer
5. Liver Cancer
6. Other Cancers
Data Sources
This report is built using data and information sourced from proprietary databases, primary and
secondary research and in–house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non–
printable sources like search engines, News websites, Government Websites, Trade Journals,
White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books,
Industry Portals, Industry Associations and access to more than 500 paid databases.
© Renub Research Page 4 of 14
About Us
RReennuubb RReesseeaarrcchh is a leading Market Research and Information Analysis Company with
centers at Noida India and Roswell USA. We have long–term experience especially in
international Business–to–Business Researches, Surveys, Business and Consulting. Throughout
the years we have acquired expertise in most market sectors, including Information Technology
(IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking,
Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer
Goods, Logistics, Governmental, Social, and Others.
Our core team is comprised of an experienced people holding graduate, post graduate and
Ph.D. degrees in Finance, Marketing, Human Resource, Bio–Technology, Medicine, Information
Technology, Environmental Science and many more. Our research help make the business
decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We
support many blue chip companies by providing them findings and perspectives across a wide
range of markets. Our research reports offer a blend of information insight, analysis and
forecasting that is essential in today’s ultra–competitive markets.
For more information on us or to view any of our sample work you can mail
us at [email protected]
© Renub Research Page 5 of 14
Published
By
RReennuubb RReesseeaarrcchh
1st Floor,
C – 86, Sector – 10
Noida – 201301
Phone: +91–120–421–9822, 424-9780 (India)
+1–678–302–0700 (USA)
Email: [email protected]
www.renub.com
© United States – Liquid Biopsy Potential Testing Market & Volume Analysis to 2020
Renub Research, 2016
Edition 1.0
All rights reserved. This publication is protected
by copyright. No part of it may be reproduced, stored
in a retrieval system or transmitted, in any form or by
any means, electronic mechanical, photocopying,
recording or otherwise without the prior written
permission of the publishers
© Renub Research Page 6 of 14
Table of Contents
1. Executive Summary
2. United States - Liquid Biopsy Potential Market (2015 – 2020)
2.1 United States - Liquid Biopsy Potential Market
2.2 United States - Liquid Biopsy Screening Potential Market
2.3 United States - Liquid Biopsy Treatment Monitoring Potential Market
3. United States - Liquid Biopsy Potential Test Volume (2015 – 2020)
3.1 United States - Liquid Biopsy Potential Test Volume
3.2 United States - Liquid Biopsy Potential Screening Test Volume
3.3 United States - Liquid Biopsy Potential Treatment Monitoring Test Volume
4. United States - Liquid Biopsy Potential Market Share (2015 – 2020)
4.1 United States - Liquid Biopsy Potential Market Share by Method
4.2 United States - Liquid Biopsy Screening Potential Market Share by Cancer Types
4.3 United States - Liquid Biopsy Treatment Monitoring Potential Market Share by Cancer Types
5. United States - Liquid Biopsy Potential Market & Test Volume by Cancer Types (2015 – 2020)
5.1 United States - Liquid Biopsy Lung Cancer Potential Market & Test Volume
5.1.1 United States - Liquid Biopsy Lung Cancer Potential Market
5.1.2 United States - Liquid Biopsy Lung Cancer Potential Test Volume
5.2 United States - Liquid Biopsy Breast Cancer Potential Market & Test Volume
5.2.1 United States - Liquid Biopsy Breast Cancer Potential Market
5.2.2 United States - Liquid Biopsy Breast Cancer Potential Test Volume
5.3 United States - Liquid Biopsy Colorectal Cancer Potential Market & Test Volume
5.3.1 United States - Liquid Biopsy Colorectal Cancer Potential Market
5.3.2 United States - Liquid Biopsy Colorectal Cancer Potential Test Volume
© Renub Research Page 7 of 14
5.4 United States - Liquid Biopsy Prostate Cancer Potential Market & Test Volume
5.4.1 United States - Liquid Biopsy Prostate Cancer Potential Market
5.4.2 United States - Liquid Biopsy Prostate Cancer Potential Test Volume
5.5 United States - Liquid Biopsy Liver Cancer Potential Market & Test Volume
5.5.1 United States - Liquid Biopsy Liver Cancer Potential Market
5.5.2 United States - Liquid Biopsy Liver Cancer Potential Test Volume
6. United States - Liquid Biopsy Screening Potential Market & Test Volume by Cancer Types
(2015 – 2020)
6.1 United States - Liquid Biopsy Lung Cancer Screening Potential Market & Test Volume
6.1.1 United States - Liquid Biopsy Lung Cancer Screening Potential Market
6.1.2 United States - Liquid Biopsy Lung Cancer Screening Potential Test Volume
6.2 United States - Liquid Biopsy Breast Cancer Screening Potential Market & Test Volume
6.2.1 United States - Liquid Biopsy Breast Cancer Screening Potential Market
6.2.2 United States - Liquid Biopsy Breast Cancer Screening Potential Test Volume
6.3 United States - Liquid Biopsy Colorectal Cancer Screening Potential Market & Test Volume
6.3.1 United States - Liquid Biopsy Colorectal Cancer Screening Potential Market
6.3.2 United States - Liquid Biopsy Colorectal Cancer Screening Potential Test Volume
6.4 United States - Liquid Biopsy Prostate Cancer Screening Potential Market & Test Volume
6.4.1 United States - Liquid Biopsy Prostate Cancer Screening Potential Market
6.4.2 United States - Liquid Biopsy Prostate Cancer Screening Potential Test Volume
6.5 United States - Liquid Biopsy Liver Cancer Screening Potential Market & Test Volume
6.5.1 United States - Liquid Biopsy Liver Cancer Screening Potential Market
6.5.2 United States - Liquid Biopsy Liver Cancer Screening Potential Test Volume
7. United States - Liquid Biopsy Treatment Monitoring Potential Market & Test Volume by Cancer
Types (2015 – 2020)
© Renub Research Page 8 of 14
7.1 United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Market & Test Volume
7.1.1 United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Market
7.1.2 United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Test Volume
7.2 United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Market & Test
Volume
7.2.1 United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Market
7.2.2 United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Test Volume
7.3 United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Market & Test
Volume
7.3.1 United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Market
7.3.2 United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Test
Volume
7.4 United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Market & Test
Volume
7.4.1 United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Market
7.4.2 United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Test Volume
7.5 United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Market & Test Volume
7.5.1 United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Market
7.5.2 United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Test Volume
7.6 United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Market & Test
Volume
7.6.1 United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Market
7.6.2 United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Test Volume
8. Liquid Biopsy Market – Recent Development
9. Liquid Biopsy Market – Major Deals Analysis
10. Liquid Biopsy Market – Driving Factors
© Renub Research Page 9 of 14
10.1 Real-Time Evaluation, Convenient and Accuracy
10.2 Increasing Demand for Minimally-Invasive Biopsy Techniques
10.3 Technical Advancement & Personalized Therapies
11. Liquid Biopsy Market – Challenges
11.1 Barriers for Liquid Biopsies
11.1.1 Comparatively Low Concentration of Molecular Biomarkers in Body Fluids
11.1.2 Low Concentration of Target DNA in A Plasma Sample
11.1.3 Proper Handling and Storage of the Samples Critical
List of Figures:
Figure 2-1: United States - Liquid Biopsy Potential Market (Million US$), 2015 - 2020
Figure 2-2: United States - Liquid Biopsy Screening Potential Market (Million US$), 2015 - 2020
Figure 2-3: United States - Liquid Biopsy Treatment Monitoring Potential Market (Million US$), 2015 - 2020
Figure 3-1: United States - Liquid Biopsy Potential Test Volume (Number), 2015 - 2020
Figure 3-2: United States - Liquid Biopsy Potential Screening Test Volume (Number), 2015 - 2020
Figure 3-3: United States - Liquid Biopsy Potential Treatment Monitoring Test Volume (Number), 2015 -
2020
Figure 4-1: United States – Method Wise Liquid Biopsy Potential Market Share (Percent), 2015 - 2020
Figure 4-2: United States - Liquid Biopsy Screening Potential Market Share by Cancer Types (Percent),
2015 - 2020
Figure 4-3: United States - Liquid Biopsy Treatment Monitoring Potential Market Share by Cancer Types
(Percent), 2015 - 2020
Figure 5-1: United States - Liquid Biopsy Lung Cancer Potential Market (Million US$), 2015 - 2020
Figure 5-2: United States - Liquid Biopsy Lung Cancer Potential Test Volume (Number), 2015 - 2020
Figure 5-3: United States - Liquid Biopsy Breast Cancer Potential Market (Million US$), 2015 - 2020
Figure 5-4: United States - Liquid Biopsy Breast Cancer Potential Test Volume (Number), 2015 - 2020
Figure 5-5: United States - Liquid Biopsy Colorectal Cancer Potential Market (Million US$), 2015 - 2020
Figure 5-6: United States - Liquid Biopsy Colorectal Cancer Potential Test Volume (Number), 2015 - 2020
Figure 5-7: United States - Liquid Biopsy Prostate Cancer Potential Market (Million US$), 2015 - 2020
© Renub Research Page 10 of 14
Figure 5-8: United States - Liquid Biopsy Prostate Cancer Potential Test Volume (Number), 2015 - 2020
Figure 5-9: United States - Liquid Biopsy Liver Cancer Potential Market (Million US$), 2015 - 2020
Figure 5-10: United States - Liquid Biopsy Liver Cancer Potential Test Volume (Number), 2015 - 2020
Figure 6-1: United States - Liquid Biopsy Lung Cancer Screening Potential Market (Million US$), 2015 -
2020
Figure 6-2: United States - Liquid Biopsy Lung Cancer Screening Potential Test Volume (Number), 2015 -
2020
Figure 6-3: United States - Liquid Biopsy Breast Cancer Screening Potential Market (Million US$), 2015 -
2020
Figure 6-4: United States - Liquid Biopsy Breast Cancer Screening Potential Test Volume (Number), 2015 -
2020
Figure 6-5: United States - Liquid Biopsy Colorectal Cancer Screening Potential Market (Million US$), 2015
- 2020
Figure 6-6: United States - Liquid Biopsy Colorectal Cancer Screening Potential Test Volume (Number),
2015 - 2020
Figure 6-7: United States - Liquid Biopsy Prostate Cancer Screening Potential Market (Million US$), 2015 -
2020
Figure 6-8: United States - Liquid Biopsy Prostate Cancer Screening Potential Test Volume (Number),
2015 - 2020
Figure 6-9: United States - Liquid Biopsy Liver Cancer Screening Potential Market (Million US$), 2015 -
2020
Figure 6-10: United States - Liquid Biopsy Liver Cancer Screening Potential Test Volume (Number), 2015
– 2020
Figure 7-1: United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Market (Million
US$), 2015 - 2020
Figure 7-2: United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Test Volume
(Number), 2015 - 2020
Figure 7-3: United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Market (Million
US$), 2015 - 2020
Figure 7-4: United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Test Volume
(Number), 2015 - 2020
Figure 7-5: United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Market (Million
US$), 2015 - 2020
Figure 7-6: United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Test Volume
(Number), 2015 - 2020
© Renub Research Page 11 of 14
Figure 7-7: United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Market (Million
US$), 2015 - 2020
Figure 7-8: United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Test Volume
(Number), 2015 - 2020
Figure 7-9: United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Market (Million
US$), 2015 - 2020
Figure 7-10: United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Test Volume
(Number), 2015 - 2020
Figure 7-11: United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Market (Million
US$), 2015 - 2020
Figure 7-12: United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Test Volume
(Number), 2015 - 2020
© Renub Research Page 12 of 14
Order Form
Scan and e-mail this page to [email protected], alternatively one can also write the Contact
Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780
Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to
Format
Report Title:
1. Liquid Biopsy Potential Testing Market & Volume Analysis to 2020 -
United States
Single User (Email from Publisher)
Hard Copy (Mail Delivery)
CD – Rom (Mail Delivery)
Global Site License (Multiple User License)
US$ 900 US$ 1000 US$ 1000 US$ 1400
For ordering this report: Easy ways to place your order:
1) Order online by Credit Card (Visa, MasterCard, etc.):
http://www.renub.com/united-states-liquid-biopsy-potential-testing-market-
and-volume-analysis-to-2020-515-p.php
© Renub Research Page 13 of 14
Bank Details
Account Name: Renub Research
A/C No.: 109102000023296
Name of Bank: IDBI Bank Ltd.
Swift Code: IBKLINBB010
Bank Address: 4th Floor
Indian Red Cross Building
1 Red Cross Road
Opposite Parliament Street
New Delhi – 110001
India
Contact Information
First Name: Last Name:
Email:
Job Title:
Company:
Address:
City:
Postal/Zip Code:
Country:
Phone:
Mobile:
Fax:
Report Format:
Your message:
© Renub Research Page 14 of 14
3) Order by Check
Please post the check accompanied by this form, to:
Company Address: Renub Research
1st Floor
C-86, Sector -10
Noida - 201301
Uttar Pradesh
India
Phone: +91-120-421-9822, 424-9780
For free Sample copy report or to view any of our sample work please contact us at
[email protected] or call +91-120-421-9822 (India), +1-678-302-0700 (USA)
Follow Us
Facebook: https://www.facebook.com/RenubResearch
LinkedIn: https://www.linkedin.com/company/renub-research
Twitter: https://twitter.com/renubresearch
Google+: https://plus.google.com/+renubresearch